The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production
Bradda Head Lithium exceeds targets, secures US$3 million royalty and moves closer to productionView Video
IntelliAM aiming for significant growth with £5 million Aquis IPO
IntelliAM aiming for significant growth with £5 million Aquis IPOView Video

Latest Share Chat

Board Appointment

6 Feb 2012 14:00

RNS Number : 8693W
Croda International PLC
06 February 2012
 



6 February 2012

 

Croda International Plc

 

Appointment of Chief Technology Officer

Croda International Plc, the speciality chemicals company, is pleased to announce that Keith Layden has been appointed to the Board as an executive director with immediate effect, in the new role of Chief Technology Officer.

Keith joined Croda in 1984 and for the past 7 years has been President of our Enterprise Technology and Actives businesses, where he has overseen significant growth in innovation and expansion into new product areas. Prior to this he held a number of Managing Director roles across our European business. As Chief Technology Officer, Keith will be responsible for accelerating the identification, development, licensing and acquisition of innovative technologies, the global co-ordination of Croda's R&D activities and the development of novel production processes for our major existing core product platforms.

Steve Foots, Croda's Chief Executive, commented,

"Keith's appointment to the Board is recognition of the importance the capture of external technologies is to our short and medium term growth plans. This is an exciting new role for Keith and the organisation."

Martin Flower, Croda's Chairman, commented,

 "We are delighted that Keith has joined the Croda Board in this important new role. His wealth of experience of the chemical industry and its related technologies will be of great value during the next phase of Croda's development. "

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

Enquiries:

Ben Foster, Pendomer Communications

020 3603 5221

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABXGDDCBGBGDL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.